MA26966A1 - Nouveaux composes utilisables en tant qu'inhibiteurs de protease hiv - Google Patents
Nouveaux composes utilisables en tant qu'inhibiteurs de protease hivInfo
- Publication number
- MA26966A1 MA26966A1 MA27172A MA27172A MA26966A1 MA 26966 A1 MA26966 A1 MA 26966A1 MA 27172 A MA27172 A MA 27172A MA 27172 A MA27172 A MA 27172A MA 26966 A1 MA26966 A1 MA 26966A1
- Authority
- MA
- Morocco
- Prior art keywords
- protease inhibitors
- novel compounds
- hiv protease
- hiv
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0028483.6A GB0028483D0 (en) | 2000-11-22 | 2000-11-22 | Hydroxyethylamine HIV protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26966A1 true MA26966A1 (fr) | 2004-12-20 |
Family
ID=9903670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27172A MA26966A1 (fr) | 2000-11-22 | 2003-05-22 | Nouveaux composes utilisables en tant qu'inhibiteurs de protease hiv |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6472404B1 (fr) |
| EP (1) | EP1339692A1 (fr) |
| JP (1) | JP2004520283A (fr) |
| KR (1) | KR20030060953A (fr) |
| CN (1) | CN1476436A (fr) |
| AR (1) | AR031763A1 (fr) |
| AU (2) | AU2954602A (fr) |
| BG (1) | BG107839A (fr) |
| BR (1) | BR0115566A (fr) |
| CA (1) | CA2428459A1 (fr) |
| CZ (1) | CZ20031667A3 (fr) |
| EC (1) | ECSP034618A (fr) |
| GB (1) | GB0028483D0 (fr) |
| GT (1) | GT200100233A (fr) |
| HU (1) | HUP0303007A2 (fr) |
| IL (1) | IL155573A0 (fr) |
| MA (1) | MA26966A1 (fr) |
| MX (1) | MXPA03004534A (fr) |
| NO (1) | NO20032290D0 (fr) |
| NZ (1) | NZ525550A (fr) |
| PA (1) | PA8533401A1 (fr) |
| PE (1) | PE20020610A1 (fr) |
| PL (1) | PL366704A1 (fr) |
| RU (1) | RU2265016C2 (fr) |
| SK (1) | SK7602003A3 (fr) |
| UY (1) | UY27033A1 (fr) |
| WO (1) | WO2002042277A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4953297B2 (ja) * | 2004-09-15 | 2012-06-13 | 塩野義製薬株式会社 | Ｈｉｖインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体 |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| MX2010010471A (es) * | 2008-03-26 | 2010-10-20 | Daiichi Sankyo Co Ltd | Derivado de tetrahidroisoquinolina novedoso. |
| US12083099B2 (en) | 2020-10-28 | 2024-09-10 | Accencio LLC | Methods of treating symptoms of coronavirus infection with viral protease inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8927913D0 (en) | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
| MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
| US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
-
2000
- 2000-11-22 GB GBGB0028483.6A patent/GB0028483D0/en not_active Ceased
-
2001
- 2001-11-12 HU HU0303007A patent/HUP0303007A2/hu unknown
- 2001-11-12 NZ NZ525550A patent/NZ525550A/en unknown
- 2001-11-12 BR BR0115566-0A patent/BR0115566A/pt not_active IP Right Cessation
- 2001-11-12 AU AU2954602A patent/AU2954602A/xx active Pending
- 2001-11-12 KR KR10-2003-7006907A patent/KR20030060953A/ko not_active Ceased
- 2001-11-12 CZ CZ20031667A patent/CZ20031667A3/cs unknown
- 2001-11-12 EP EP01990405A patent/EP1339692A1/fr not_active Withdrawn
- 2001-11-12 MX MXPA03004534A patent/MXPA03004534A/es active IP Right Grant
- 2001-11-12 IL IL15557301A patent/IL155573A0/xx unknown
- 2001-11-12 WO PCT/EP2001/013068 patent/WO2002042277A1/fr not_active Ceased
- 2001-11-12 AU AU2002229546A patent/AU2002229546B2/en not_active Ceased
- 2001-11-12 PL PL01366704A patent/PL366704A1/xx not_active Application Discontinuation
- 2001-11-12 CN CNA018192890A patent/CN1476436A/zh active Pending
- 2001-11-12 CA CA002428459A patent/CA2428459A1/fr not_active Abandoned
- 2001-11-12 RU RU2003117468/04A patent/RU2265016C2/ru not_active IP Right Cessation
- 2001-11-12 SK SK760-2003A patent/SK7602003A3/sk unknown
- 2001-11-12 JP JP2002544412A patent/JP2004520283A/ja active Pending
- 2001-11-20 US US09/999,082 patent/US6472404B1/en not_active Expired - Fee Related
- 2001-11-21 UY UY27033A patent/UY27033A1/es not_active Application Discontinuation
- 2001-11-21 PA PA20018533401A patent/PA8533401A1/es unknown
- 2001-11-21 AR ARP010105431A patent/AR031763A1/es unknown
- 2001-11-21 GT GT200100233A patent/GT200100233A/es unknown
- 2001-11-22 PE PE2001001170A patent/PE20020610A1/es not_active Application Discontinuation
-
2003
- 2003-05-21 EC EC2003004618A patent/ECSP034618A/es unknown
- 2003-05-21 NO NO20032290A patent/NO20032290D0/no unknown
- 2003-05-22 BG BG107839A patent/BG107839A/bg unknown
- 2003-05-22 MA MA27172A patent/MA26966A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2265016C2 (ru) | 2005-11-27 |
| PE20020610A1 (es) | 2002-07-13 |
| RU2003117468A (ru) | 2005-01-27 |
| BR0115566A (pt) | 2003-09-30 |
| AU2002229546B2 (en) | 2006-05-04 |
| ECSP034618A (es) | 2003-06-25 |
| CN1476436A (zh) | 2004-02-18 |
| JP2004520283A (ja) | 2004-07-08 |
| NO20032290L (no) | 2003-05-21 |
| CZ20031667A3 (cs) | 2004-01-14 |
| KR20030060953A (ko) | 2003-07-16 |
| UY27033A1 (es) | 2002-06-20 |
| CA2428459A1 (fr) | 2002-05-30 |
| PA8533401A1 (es) | 2002-10-31 |
| US6472404B1 (en) | 2002-10-29 |
| IL155573A0 (en) | 2003-11-23 |
| AU2954602A (en) | 2002-06-03 |
| GT200100233A (es) | 2002-07-04 |
| HUP0303007A2 (hu) | 2003-12-29 |
| EP1339692A1 (fr) | 2003-09-03 |
| AR031763A1 (es) | 2003-10-01 |
| GB0028483D0 (en) | 2001-01-10 |
| MXPA03004534A (es) | 2003-09-10 |
| NO20032290D0 (no) | 2003-05-21 |
| NZ525550A (en) | 2004-11-26 |
| BG107839A (bg) | 2004-06-30 |
| WO2002042277A1 (fr) | 2002-05-30 |
| SK7602003A3 (en) | 2004-01-08 |
| PL366704A1 (en) | 2005-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR22C1036I1 (fr) | Derives d'une pyrimidine en tant qu'inhibiteur du vih | |
| FR15C0086I2 (fr) | Derives d'hydroxamate en tant qu'inhibiteurs de desacetylase | |
| EP1165541A4 (fr) | Composes dimeres en tant qu'inhibiteurs de la neuraminidase | |
| EP1549315A4 (fr) | Composes de dihydroxypyridopyrazine-1,6-diones utiles en tant qu'inhibiteurs de l'integrase du vih | |
| MA26972A1 (fr) | Derives du tetralone en tant qu'agents anti-tumeur | |
| MA26782A1 (fr) | Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2. | |
| MA26994A1 (fr) | Quinazolines en tant qu'inhibiteurs de la mmp-13 | |
| MA27126A1 (fr) | 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES | |
| CY2004011I1 (el) | Aσυμμετρη συνθεση της πρεγαβαλινης | |
| GB0018828D0 (en) | Alkyl Amino Acid Derivatives useful as pharmaceutical agents | |
| AR028461A1 (es) | Composicion detergente liquida | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| DZ3246A1 (fr) | Dérivé heterocyclo-alkylsulfonyle pyrazole en tant qu'agents anti-inflammatoires/analgesiques | |
| DK1349580T4 (da) | Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning | |
| DE50101916D1 (de) | Flüssige formulierungen | |
| DE50104794D1 (de) | Substituierte anthranilsäuren | |
| MA27046A1 (fr) | Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens. | |
| DK1733725T3 (da) | Farmaceutiske formuleringer omfattende mindst én HIV-proteaseinhiberende forbindelse | |
| EP1435992A4 (fr) | Chimiokines en tant qu'agents auxiliaires de reponse immunitaire | |
| AR028607A1 (es) | Derivados de 1,4-diazepan-2,5-diona | |
| MA26966A1 (fr) | Nouveaux composes utilisables en tant qu'inhibiteurs de protease hiv | |
| AR028083A1 (es) | Una composicion de champu | |
| EP1565458A4 (fr) | Analogues azoiques dicationiques de 2,5-diarylfuranes en tant qu'agents antiprotozoaires | |
| BR0114065A (pt) | Triazolo-epotilonas | |
| MA27140A1 (fr) | Les oligopeptides et les compositions qui les contiennent en tant qu'inhibiteurs de cathepsin s |